Stay updated on Fevipiprant in COPD With Eosinophilia Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant in COPD With Eosinophilia Clinical Trial page.

Latest updates to the Fevipiprant in COPD With Eosinophilia Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check58 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of a clinical study on fevipiprant (QAW039) for chronic obstructive pulmonary disease (COPD) and the addition of a new revision number.SummaryDifference39%
- Check65 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check101 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Fevipiprant in COPD With Eosinophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant in COPD With Eosinophilia Clinical Trial page.